Folgen
Isaac Xin Pei
Titel
Zitiert von
Zitiert von
Jahr
Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a …
B O'Sullivan, SH Huang, J Su, AS Garden, EM Sturgis, K Dahlstrom, ...
The Lancet Oncology 17 (4), 440-451, 2016
7502016
Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer
MJ Zelefsky, M Kollmeier, B Cox, A Fidaleo, D Sperling, X Pei, B Carver, ...
International Journal of Radiation Oncology* Biology* Physics 84 (1), 125-129, 2012
5912012
Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer
DE Spratt, X Pei, J Yamada, MA Kollmeier, B Cox, MJ Zelefsky
International Journal of Radiation Oncology* Biology* Physics 85 (3), 686-692, 2013
2992013
Ten‐year outcomes of high‐dose, intensity‐modulated radiotherapy for localized prostate cancer
ZA Alicikus, Y Yamada, Z Zhang, X Pei, M Hunt, M Kollmeier, B Cox, ...
Cancer 117 (7), 1429-1437, 2011
2602011
Dose escalation for prostate cancer radiotherapy: predictors of long-term biochemical tumor control and distant metastases–free survival outcomes
MJ Zelefsky, X Pei, JF Chou, M Schechter, M Kollmeier, B Cox, Y Yamada, ...
European urology 60 (6), 1133-1139, 2011
2252011
Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma
MJ Zelefsky, C Greco, R Motzer, JM Magsanoc, X Pei, M Lovelock, ...
International Journal of Radiation Oncology* Biology* Physics 82 (5), 1744-1748, 2012
2222012
Metformin and prostate cancer: reduced development of castration-resistant disease and prostate cancer mortality
DE Spratt, C Zhang, ZS Zumsteg, X Pei, Z Zhang, MJ Zelefsky
European urology 63 (4), 709-716, 2013
2092013
The natural history and predictors of outcome following biochemical relapse in the dose escalation era for prostate cancer patients undergoing definitive external beam radiotherapy
ZS Zumsteg, DE Spratt, PB Romesser, X Pei, Z Zhang, W Polkinghorn, ...
European urology 67 (6), 1009-1016, 2015
1992015
Patterns of treatment failure and postrecurrence outcomes among patients with locally advanced head and neck squamous cell carcinoma after chemoradiotherapy using modern …
JE Leeman, J Li, X Pei, P Venigalla, ZS Zumsteg, E Katsoulakis, ...
JAMA oncology 3 (11), 1487-1494, 2017
1772017
Comparison of high‐dose (86.4 G y) IMRT vs combined brachytherapy plus IMRT for intermediate‐risk prostate cancer
DE Spratt, ZS Zumsteg, P Ghadjar, MA Kollmeier, X Pei, G Cohen, ...
BJU international 114 (3), 360-367, 2014
1652014
Genomic methods identify homologous recombination deficiency in pancreas adenocarcinoma and optimize treatment selection
W Park, J Chen, JF Chou, AM Varghese, KH Yu, W Wong, M Capanu, ...
Clinical Cancer Research 26 (13), 3239-3247, 2020
1622020
Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy
A Goenka, JM Magsanoc, X Pei, M Schechter, M Kollmeier, B Cox, ...
European urology 60 (6), 1142-1148, 2011
1432011
AG protein/cAMP signal cascade is required for axonal convergence into olfactory glomeruli
AT Chesler, DJ Zou, CE Le Pichon, ZA Peterlin, GA Matthews, X Pei, ...
Proceedings of the National Academy of Sciences 104 (3), 1039-1044, 2007
1422007
Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy
RM Samstein, C Krishna, X Ma, X Pei, KW Lee, V Makarov, F Kuo, ...
Nature cancer 1 (12), 1188-1203, 2020
1322020
Absence of adenylyl cyclase 3 perturbs peripheral olfactory projections in mice
DJ Zou, AT Chesler, CE Le Pichon, A Kuznetsov, X Pei, EL Hwang, ...
Journal of Neuroscience 27 (25), 6675-6683, 2007
1252007
A Phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy
Y Yamada, MA Kollmeier, X Pei, CC Kan, NC Gil'ad, SM Donat, BW Cox, ...
Brachytherapy 13 (2), 111-116, 2014
1232014
Precision radiotherapy: reduction in radiation for oropharyngeal cancer in the 30 ROC trial
N Riaz, E Sherman, X Pei, H Schöder, M Grkovski, R Paudyal, N Katabi, ...
JNCI: Journal of the National Cancer Institute 113 (6), 742-751, 2021
1172021
Incidence of secondary cancer development after high-dose intensity-modulated radiotherapy and image-guided brachytherapy for the treatment of localized prostate cancer
MJ Zelefsky, DM Housman, X Pei, Z Alicikus, JM Magsanoc, LT Dauer, ...
International Journal of Radiation Oncology* Biology* Physics 83 (3), 953-959, 2012
1132012
Comparison of tumor control and toxicity outcomes of high-dose intensity-modulated radiotherapy and brachytherapy for patients with favorable risk prostate cancer
MJ Zelefsky, Y Yamada, X Pei, M Hunt, G Cohen, Z Zhang, M Zaider
Urology 77 (4), 986-990, 2011
1122011
Long-term outcomes after high-dose postprostatectomy salvage radiation treatment
A Goenka, JM Magsanoc, X Pei, M Schechter, M Kollmeier, B Cox, ...
International Journal of Radiation Oncology* Biology* Physics 84 (1), 112-118, 2012
1092012
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20